Nejm.org

Original Article from The New England Journal of Medicine — Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

Original Article from The New England Journal of Medicine — Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

Editorial from The New England Journal of Medicine — New Promise for Vaccines against Tuberculosis

Original Article from The New England Journal of Medicine — Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

Original Article from The New England Journal of Medicine — First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Original Article from The New England Journal of Medicine — Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Original Article from The New England Journal of Medicine — Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

Original Article from The New England Journal of Medicine — Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia

Original Article from The New England Journal of Medicine — Recovery of Over-Ground Walking after Chronic Motor Complete Spinal Cord Injury

Original Article from The New England Journal of Medicine — Recovery of Over-Ground Walking after Chronic Motor Complete Spinal Cord Injury

Perspective from The New England Journal of Medicine — The Price of Crossing the Border for Medications

Original Article from The New England Journal of Medicine — Transcatheter Mitral-Valve Repair in Patients with Heart Failure

Images in Clinical Medicine from The New England Journal of Medicine — Elemental Mercury Embolism to the Lung

Perspective from The New England Journal of Medicine — Doctoring while Sick — Is Living with Cancer Making Me a Better or Worse Doctor?

Correspondence from The New England Journal of Medicine — Trends in Modern Phase 1 Oncology Trials